Literature DB >> 16712669

Effect of obesity and morbid obesity on the growth hormone (GH) secretion elicited by the combined GHRH + GHRP-6 test.

Fahrettin Kelestimur1, Vera Popovic, Alfonso Leal, P Sytze Van Dam, Elena Torres, Luisa F Perez Mendez, Yona Greenman, Hans P F Koppeschaar, Carlos Dieguez, Felipe F Casanueva.   

Abstract

OBJECTIVE: Obesity is characterized by low basal levels of growth hormone (GH) and impeded GH release. However, the main problem arises in the diagnosis of GH deficiency in adults, as all accepted cut-offs in the diagnostic tests of GH reserve are no longer valid in obese subjects. In this work, the role of obesity in the GH response elicited by the GHRH + GHRP-6 test was assessed in a large population of obese and nonobese subjects. PATIENTS: GHRH + GHRP-6-induced GH peaks were evaluated in 542 subjects. One hundred and five were healthy obese, 50 were morbid obese, and 261 were nonobese (both normal weight and overweight). One hundred and seventy-six GH-deficient patients (obese and nonobese) were also studied.
RESULTS: A regression analysis of the 366 subjects with normal pituitary function indicated that adiposity had a negative effect on the elicited GH peak (r = -0.503, P < 0.0001). A receiver operating characteristic (ROC) curve analysis showed that in subjects with a BMI < or =35, the currently accepted cut-offs of the GHRH + GHRP-6 test (GH peaks > or =20 microg/l: normal secretion; GH peaks < or =10 microg/l: GH deficiency), were fully operative. However, in subjects with a BMI > 35, normality was indicated by GH peaks > or =15 microg/l and GH deficiency by peaks < or =5 microg/l (1 microg/l = 2.6 mU/l).
CONCLUSIONS: This study confirms: (a) that the combined provocative test is adequate to separate normal and GH-deficient subjects; (b) the negative effect of obesity on GH secretion; (c) that obesity accounts for 25% of the reduction of GH release; and (d) that present cut-off values are applicable to normal weight, overweight and grade I obesity subjects, whereas in obese subjects with a BMI exceeding 35, all the normative limits of the GHRH-GHRP +6 test must be reduced by 5 microg/l.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712669     DOI: 10.1111/j.1365-2265.2006.02525.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Can a glucagon stimulation test characterized by lower GH cut-off value be used for the diagnosis of growth hormone deficiency in adults?

Authors:  Halit Diri; Zuleyha Karaca; Yasin Simsek; Fatih Tanriverdi; Kursad Unluhizarci; Ahmet Selcuklu; Fahrettin Kelestimur
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

2.  IGFBP4 Is Required for Adipogenesis and Influences the Distribution of Adipose Depots.

Authors:  David E Maridas; Victoria E DeMambro; Phuong T Le; Subburaman Mohan; Clifford J Rosen
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

Review 3.  Clinical and diagnostic approach to patients with hypopituitarism due to traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), and ischemic stroke (IS).

Authors:  Ioannis Karamouzis; Loredana Pagano; Flavia Prodam; Chiara Mele; Marco Zavattaro; Arianna Busti; Paolo Marzullo; Gianluca Aimaretti
Journal:  Endocrine       Date:  2015-11-16       Impact factor: 3.633

Review 4.  Diagnosis of adult GH deficiency.

Authors:  V Gasco; G Corneli; S Rovere; C Croce; G Beccuti; A Mainolfi; S Grottoli; G Aimaretti; E Ghigo
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood - call for attention.

Authors:  Milica Medic-Stojanoska; Sandra Pekic; Nikola Curic; Dragana Djilas-Ivanovic; Vera Popovic
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

6.  Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.

Authors:  I Sadaf Farooqi; Teresia Wangensteen; Stephan Collins; Wendy Kimber; Giuseppe Matarese; Julia M Keogh; Emma Lank; Bill Bottomley; Judith Lopez-Fernandez; Ivan Ferraz-Amaro; Mehul T Dattani; Oya Ercan; Anne Grethe Myhre; Lars Retterstol; Richard Stanhope; Julie A Edge; Sheila McKenzie; Nader Lessan; Maryam Ghodsi; Veronica De Rosa; Francesco Perna; Silvia Fontana; Inês Barroso; Dag E Undlien; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

Review 7.  Pituitary and/or hypothalamic dysfunction following moderate to severe traumatic brain injury: Current perspectives.

Authors:  Zeeshan Javed; Unaiza Qamar; Thozhukat Sathyapalan
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

Review 8.  Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.

Authors:  Ginevra Corneli; Valentina Gasco; Flavia Prodam; Silvia Grottoli; Gianluca Aimaretti; Ezio Ghigo
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

9.  Hypopituitarism in Traumatic Brain Injury-A Critical Note.

Authors:  Marianne Klose; Ulla Feldt-Rasmussen
Journal:  J Clin Med       Date:  2015-07-14       Impact factor: 4.241

Review 10.  Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment.

Authors:  Valentina Gasco; Valeria Cambria; Fabio Bioletto; Ezio Ghigo; Silvia Grottoli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-15       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.